Parties will establish a Center of Excellence in CMIC’s NJ plant.
CMIC CMO USA Corporation, a subsidiary of contract development and manufacturing organization (CDMO), CMIC CMO Co., Ltd., and Rutgers University, are partnering up to further grow the advanced pharmaceutical manufacturing field. Specifically, the parties have agreed to join forces to establish a Center of Excellence in advanced pharmaceutical manufacturing, co-located at CMIC’s 224,000 square-foot facility in New Jersey.
Since 2006, the Rutgers School of Engineering has been a pharmaceutical research contributor through the Center for Structured Organic Particulate Systems (C-SOPS). C-SOPS has assembled a cross-disciplinary team of researchers from major universities, working in close collaboration with industry leaders and regulatory authorities to improve pharmaceutical, food, and agricultural product manufacturing methods.
“We are very excited about this partnership. CMIC and Rutgers’ shared commitment to innovation and excellence fully aligns with our vision,” says Makoto Matsukawa, CEO of CMIC CMO. “Together, we can enhance pharmaceutical manufacturing technologies and processes, contributing to the industry’s global advancement.”
Strategic Trends in Pharmaceutical Manufacturing for Industry Leaders
March 10th 2025This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory changes, and evolving market dynamics, requiring industry leaders to adopt innovative strategies in order to remain competitive.